BCMA-CAR-T in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT03664661 · UNKNOWN

Trial details

NCT number: NCT03664661
Sponsor: Henan Cancer Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Myeloma

Start date: 2018-04-11
Primary completion: 2019-04-10
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.